These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours. Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303 [TBL] [Abstract][Full Text] [Related]
11. How to count mitoses in bladder cancer grading? Lipponen PK; Eskelinen MJ Anticancer Res; 1991; 11(2):825-9. PubMed ID: 2064337 [TBL] [Abstract][Full Text] [Related]
12. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group. Liukkonen T; Rajala P; Raitanen M; Rintala E; Kaasinen E; Lipponen P Eur Urol; 1999 Nov; 36(5):393-400. PubMed ID: 10516448 [TBL] [Abstract][Full Text] [Related]
14. Prediction of superficial bladder cancer by histoquantitative methods. Lipponen PK; Eskelinen MJ; Sotarauta M Eur J Cancer; 1990; 26(10):1060-3. PubMed ID: 2148881 [TBL] [Abstract][Full Text] [Related]
15. Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer. Lipponen PK; Collan Y; Eskelinen MJ Int Surg; 1991; 76(4):245-9. PubMed ID: 1663917 [TBL] [Abstract][Full Text] [Related]
16. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors. Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Smeets AW; Pauwels RP Cancer; 2000 Jun; 88(11):2598-605. PubMed ID: 10861439 [TBL] [Abstract][Full Text] [Related]
17. Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer. Lillesand M; Kvikstad V; Mangrud OM; Gudlaugsson E; van Diermen-Hidle B; Skaland I; Baak JPA; Janssen EAM PLoS One; 2020; 15(6):e0233676. PubMed ID: 32484812 [TBL] [Abstract][Full Text] [Related]
18. Mitotic indexes as prognostic predictors in female breast cancer. Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263 [TBL] [Abstract][Full Text] [Related]
19. A simplified grading method of transitional cell carcinoma of the urinary bladder: reproducibility, clinical significance and comparison with other prognostic parameters. Schapers RF; Pauwels RP; Wijnen JT; Arends JW; Thunnissen FB; Coebergh JW; Smeets AW; Bosman FT Br J Urol; 1994 Jun; 73(6):625-31. PubMed ID: 8032828 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB; Zeng FH; Sun ZQ Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]